IRB Meeting Dates and Submission Deadlines
MCP IRB committee meets every 2nd Wednesday of each month from 12:00 PM to 1:00 PM. Per regulations, IRB members must be provided with research materials sufficiently in advance to allow review of the material to prepare for any deliberation and voting. Per local policy, this is generally one week before the meeting. Therefore, the submission deadline is ten (10) business days before each IRB meeting to allow for any changes and to meet the review timeline. Submit materials following the IRB submission checklist and instructions on each applicable form.
Below is a schedule of IRB meetings and submission deadlines for Initial, continuing and amendment (modification) applications that involve greater than minimal risk to subjects. Submit all documents via irbnet.org. For all IRB submissions, an original signature is not required. The Principal Investigator must sign all packages before they are submitted for IRB review.
|IRB Meeting Date||Submission Deadline|
|January 9, 2019||December 26, 2018|
|February 13, 2019||January 30, 2019|
|March 13, 2019||February 27, 2019|
|April 10, 2019||March 27, 2019|
|May 8, 2019||April 24, 2019|
|June 12, 2019||May 29, 2019|
|July 10, 2019||June 26, 2019|
|August 14, 2019||July 31, 2019|
|September 11, 2019||August 28, 2019|
|October 9, 2019||September 25, 2019|
|November 13, 2019||October 30, 2019|
|December 11, 2019||November 27, 2019|
|January 8, 2020||December 25, 2019|
|February 12, 2020||January 29, 2020|
|March 11, 2020||February 26, 2020|
|April 8, 2020||March 25, 2020|
*Note: Submissions received on the deadline date must be complete and review ready to be placed on the Agenda for review at next convened board meeting.
Training and Education
MCP IRB requires all individuals involved in the conduct of human subjects research to complete human subjects protection training and to ensure that training is current for every year while the study is under active IRB oversight. IRB approval will be withheld if these training requirements are not met.
These requirements apply to all persons with a significant role in the research, such as those designated as:
- Principal Investigator and Co-investigators,
- Individuals named on a study grant or contract proposal,
- Individuals listed on an FDA form 1572 for the conduct of the research at MCP or at an affiliate institution,
- Individuals named as a contact person in the informed consent document(s) or recruitment materials for research,
- Individuals who obtain informed consent from prospective participants in research, and
- Individuals who obtain individually identifiable health information under a Business Associate Agreement.
At a minimum, MCP IRB will accept evidence of completion of the online National Institutes of Health (NIH) Office of Extramural Research module entitled “Protecting Human Research Participants” or The Collaborative Institutional Training Initiative (CITI) program training.
If training was completed at another institution, please upload a copy of the training certificate to IRBNet with the materials for the particular review package.